Regional Central Database Recording of Chronic Myeloid Leukemia
NCT ID: NCT02869256
Last Updated: 2017-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2014-01-31
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Indeed , the main purpose of this database is to provide diagnostic and therapeutic management of reported cases of chronic myeloid leukemia and to study the prognostic factors . The main objective is to improve significantly the percentage of patients treated adequately load in the region, in the initial stages of the disease and during its evolution.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Practices evaluation
Practices evaluation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* male or female patient aged 18 years or more
* Cases transmitted by referring hematologist , one of the 6 participating centers after patient's oral information
* Clinical record presented Concertation Meeting LMC Multidisciplinary coordinated by the Institute Bergonié
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Bergonié
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Polyclinique Bordeaux Nord
Bordeaux, , France
Centre Hospitalier Universitaire de Bordeaux
Bordeaux, , France
Institut Bergonié
Bordeaux, , France
Centre Hospitalier Universitaire de Dax
Dax, , France
Centre hospitalier Libourne
Libourne, , France
Centre Hospitalier Universitaire de Pau
Pau, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Olivier FITOUSSI
Role: primary
François Xavier Mahon, MD PhD
Role: primary
Gabriel Etienne
Role: primary
François LIFERMANN
Role: primary
Joël CECCALDI
Role: primary
Corinne Dagada
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IB2014-LMC
Identifier Type: -
Identifier Source: org_study_id